CLINICAL_TRIALS
trial_result
· 2020-06-16
Clinical Trial Update: MLE4901 vs. Placebo for the Treatment of PCOS [Phase 2]
Summary
Phase 2 trial of MLE4901 versus placebo for polycystic ovary syndrome (PCOS) was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millendo Therapeutics US, Inc. | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 2 | Status: TERMINATED | Results posted: 2020-06-16